Chondroitin Market Analysis

Chondroitin is being used in the drugs for heart problems, breast cancer, interstitial cystitis, psoriasis, and many other diseases. It is also being used to treat anemia in complex with iron. These benefits have led to the increased use of chondroitin in dietary supplements. The use of chondroitin is not only limited to nutraceuticals but is also being used as a pharmaceutical drug along with others. It is being used as an eye drop and has been approved by the FDA for the same purpose. The use of chondroitin in the cosmetics industry is very less but it is expected to grow in the upcoming years.

Chondroitin Market: Key Developments

Many manufacturers sell the dietary supplements and their label indicates the presence of chondroitin in them. But the quantity of chondroitin is as little as 10% which results in low-quality products. But many manufacturers are trying to clean up the supply chain of chondroitin. Synutra Ingredients is using gel electrophoresis to stop adulteration of chondroitin and is one of the leading manufacturers of chondroitin in the United States.

Chondroitin Market: Regional Analysis

The production is mainly carried out in the Asia Pacific especially in China. The consumption of chondroitin is more in the U.S. and all the chondroitin that is consumed in the U.S. is imported from overseas. Chondroitin-containing supplements are one of the top five best-selling dietary supplements globally. The use of chondroitin as a dietary supplement is expected to increase in South and East Asia in the upcoming years. It is being widely used in Europe and MEA in cosmetics and personal care products. The chondroitin is being sold by various different names one of them being chondroitin sulfate which is very popular.  

Chondroitin Market: Key Participants

The key participants in the chondroitin market are:

• TSI Group Ltd.
• Synutra Pure, Ltd.
• Bioiberica S.A.U.
• Kala Health Inc.
• Shanghai Jbichem International Trading Co. Ltd.
• Summit Nutritionals International, Inc. 
• Pacific Rainbow International, Inc.
• Qingdao Kangyuan Pharmaceutical
• Beloorbayir Biotech Ltd.
• AdvaCare Pharma
• Sichuan Biosyn Pharmaceutical Co., Ltd.
• Inter Farma
• Jiaxing Hengjie Bio-pharmaceutical LLC
• Seikagaku Corporation 

The research report presents a comprehensive assessment of the chondroitin market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as product type, application, and end use.

The report covers exhaustive analysis on:

• Chondroitin Market Segments
• Chondroitin Market Dynamics
• Chondroitin Market Size
• Chondroitin Supply and Demand
• Current Trends/Issues/Challenges pertaining to Chondroitin Market
• Competition Landscape and Emerging Market Participants in Chondroitin Market
• Technology related to Production/Processing of Chondroitin
• Value Chain Analysis of the Chondroitin Market

Regional analysis includes:

• North America (U.S., Canada)
• Latin America (Mexico, Brazil)
• Europe (Germany, U.K., France, Italy, Spain, Poland, Russia)
• East Asia (China, Japan, South Korea)
• South Asia (India, Thailand, Malaysia, Vietnam, Indonesia)
• Oceania (Australia, New Zealand)
• Middle East & Africa (GCC Countries, Turkey, Northern Africa, South Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.